East Asia Experiencing Rapid Economic Growth, Record Low Poverty

The World Bank reports that East Asia is experiencing its fasted rate of economic growth since the 1997 financial crisis. The upshot is that the strong economic growth has lifted an estimated 40 million people out of poverty in China, Indonesia, Thailand and Vietnam.

In a press release, the World Bank’s Regional Vice President for East Asia and Pacific Mr. Jemal-ud-din Kassum said (emphasis added),

We are estimating that by the end of this year, the number of people living on less than $2 a day will be around one third of the region’s population. Even excluding China, the absolute number of poor would be at their lowest level ever, finally overcoming the higher poverty created by the 1997 crisis. This expansion is happening during a time of major political advances with a sweep of legislative and presidential elections, including Indonesia’s first ever direct election of a president, capping what looks like being a remarkable year for the region.

The main obstacle to further growth in 2005 and beyond, the World Bank notes, are continuing high oil prices which could cut 0.5 to 1 percentage point off of the current 7 percent growth rate the region is experiencing.

Economic growth, as usual, is the key to lifting people out of poverty.

Source:

East Asia Region Set To Grow by Healthy 7 Percent In 2004. Press Release, World Bank, November 9, 2004.

East Asia poverty at ‘record low’. The BBC, November 9, 2004.

Economy pushes Asia poverty down. CNN, November 8, 2004.

Cheap Antibiotic Could Cut AIDS Deaths in Children

Following the publication of a study in The Lancet on its effects, the World Health Organization is recommending that HIV-postive children in the developed world be treated with a low-cost antibiotic that appears to dramatically reduce the risk of death among such children.

A British research team conducted a clinical trial using the antibiotic co-trimoxazole to treat HIV positive children in Zambia. The researchers ended the study ahead of time because the effect was so great. After 19 months, only 25 percent of children taking the co-trimoxazole had died compared to 40 percent of the control group of children who had been given a placebo.

WHO and UNICEF are now calling for all children who are HIV positive or whose HIV status is unknown to be treated with co-trimoxazole. The drug is cheap, costing less than 10 cents to treat a person per day, making it ideal for the developing world.

Researchers had initially feared that co-trimoxazole would not be effective due to relatively high levels of antibiotic resistance in Africa, but the drug proved effective in tackling the opportunistic infections such as pneumonia and tuberculosis which kill many children with AIDS.

Source:

New low-cost HIV treatment hailed. The BBC, November 19, 2004.

Antibiotic could halve AIDS-related deaths in children. Priya Shetty. SciDev.Net, November 19, 2004.

U.S. Researchers Discover Enzyme That Could Boost Crop Resistance to Drought

Researchers at the University of California, Riverside, reported this month that they had developed a method to increase the resistance of grain crops to drought.

In research to be published in the December issue of The Plant Journal, the researchers describe how lowering the levels of an enzyme called ACC synthase in turn reduces production of ethylene. Ethylene is responsible for the deaths of leaves in response to adverse environmental conditions, such as drought.

The researchers searched through thousands of plants, looking for ones that had naturally lower levels of ACC synthase. In a press release announcing their findings, the University of California, Riverside noted,

In addition, the plants were more resistant to the effects of adverse environmental conditions. Surprisingly, by reducing the level of ethylene, all the leaves of the altered plants contained higher levels of chlorophyll and leaf protein, and functioned better than control leaves.

“Thus, they are able to survive conditions of drought and remain productive,” said Professor [Daniel] Gallie, who led a research team that included UCR Colleague Todd E. Young and Robert B. Meeley, of Pioneer Hi-Bred. “Erratic rainfall and conditions of drought have plagued farmers from time immemorial, and are responsible for substantial losses in crop yield when they do occur.”

This opens the possibility, of course, of using traditional plant breeding or genetic modification to create crop plants well suited for more arid parts of the world.

Source:

Researchers discover new way to boost grain crops’ drought tolerance. Press Release, University of California, Riverside, November 17, 2004.

Post-Thanksgiving Anti-Fur Protest in California

Sometimes, you just have to let the activists speak for themselves. These are pictures of a People for the Ethical Treatment of Animals anti-fur demonstration held on November 26 at a Santa Rosa, California mall. The woman with the club is Dr. Lisa Kemmerer and the woman on the ground is Popy Foxheart.

Source:

Fur Free Friday in Santa Rosa. Alexandra Bury, IndyBay.org, November 29, 2004.

Lanie Gunier Should Just Go Shopping

Milwaukee Journal Sentinel columnist Gregory Stanford wrote a column the other day in which he includes part of a discussion he had with Lani Guinier. Stanford includes a paraphrase of Guinier putting down the Republican Party. Stanford writes,

The Republican vision sustains a materialistic, individualistic, consumeristic culture, Guinier said.

And that’s a problem how? If the Republicans would just ditch their “morality” issues and focus on the individualistic consumerism, they’d have my vote any day of the week. (Guinier is apparently horrified that Bush urged Americans to go shopping after 9/11 — but what is more American than shopping?)

Ditch the abortion and gay stuff and focus on cutting taxes and killing terrorists — now there’s a political party I could get behind.

Guinier, on the other hand, contrasts this with the Democrats who she thinks should stress the idea of “shared responsibility and shared sacrifice.” Ugh. Thanks, but no thanks. If your religion calls for sacrifices, who am I to object, but please do it privately amongst yourselves.

Source:

It seems Democrats must work on passion, vision. Gregory Stanford, Milwaukee Journal-Sentinel, November 20, 2004.

Huntingdon Life Sciences Business and Stock Price Soars

The other day I was catching up on reading an animal rights discussion list in which someone had posted a notice that some small company or another with some tangential relationship to Huntingdon Life Sciences had severed ties with the company after animal rights extremists started harassing it. Some newbie activist was apparently thrilled at this news and sent a reply that, obviously, activists must be close to shutting down HLS and they just needed that last extra push to finish the job.

The reality is a bit different. At the end of October, HLS filed its third quarter report which showed fantastic results for the company,

Net revenues for the three months ended September 30, 2004 were $40.9 million, an increase of 24.9% on net revenues of $32.7 million for the three months ended September 30, 2003. Excluding the effect of exchange rate movements, the increase was 13.4%. UK net revenues increased by 30.0%; at constant exchange rates the increase was 15.2%. In the US, net revenues increased by 7.9%. Net new orders for the three months ended September 30, 2004 at constant exchange rates, were 31% above the same period last year. This growth in net new orders, which was particularly strong from the pharmaceutical industry, coming on top of the high level of orders taken in the first two quarters, have fed through into revenues in the quarter, but has been partly offset by a decline in non-pharmaceutical business.

. . .

Basic income per common share was 15 cents, compared to 3 cents last year on the weighted average common shares outstanding of 12,165,643 (2003: 11,932,338).

Earnings before interest, taxes, depreciation and amortization, and other income/(expense) (“EBITDA”) was $7.0 million for the third quarter of 2004, or 17.0% of revenues, compared with $3.9 million, or 11.9% of revenues for the same period in the prior year.

. . .

Net revenues for the nine months ended September 30, 2004 were $116.4 million, an increase of 19.7% on net revenues of $97.3 million for the nine months ended September 30, 2003. Excluding the effect of exchange rate movements, the increase was 8.6%. UK net revenues increased by 22.4%; at constant exchange rates the increase was 8.3%. In the US, net revenues increased by 9.9%. Net new orders for the nine months ended September 30, 2004 at constant exchange rates were 29% above the same period last year. This growth in net new orders, which was particularly strong from the pharmaceutical industry, has fed through into revenues in the nine months, but has been partly offset by a decline in non-pharmaceutical business.

While the activists seem to think they are still close to shutting down HLS after years of trying, shares in the company reached a high on November 24 of $9.75/share, after trading for less than $3 for most of the past two years since the company moved to trading in the United States.

So all of the animal rights harassment and terrorism can’t even bring down a small contract research company.

Source:

Form 10-Q for LIFE SCIENCES RESEARCH INC. October 29, 2004.